NPM1 is associated with nucleolarribonucleoprotein structures and binds single-stranded and double-stranded nucleic acids, but it binds preferentially G-quadruplex forming nucleic acids. It is involved in the biogenesis of ribosomes and may assist small basic proteins in their transport to the nucleolus. Its regulation through SUMOylation (by SENP3 and SENP5) is another facet of the proteins's regulation and cellular functions.
It is located in the nucleolus, but it can be translocated to the nucleoplasm in case of serum starvation or treatment with anticancer drugs. The protein is phosphorylated.
NPM1 gene is up-regulated, mutated and chromosomally translocated in many tumor types. Chromosomal aberrations involving NPM1 were found in patients with non-Hodgkin lymphoma, acute promyelocytic leukemia, myelodysplastic syndrome, and acute myelogenous leukemia.[4] Heterozygous mice for NPM1 are vulnerable to tumor development. In solid tumors NPM1 is frequently found overexpressed, and it is thought that NPM1 could promote tumor growth by inactivation of the tumor suppressor p53/ARF pathway; on the contrary, when expressed at low levels, NPM1 could suppress tumor growth by the inhibition of centrosome duplication.
Of high importance is NPM involvement in acute myelogenous leukemia,[5] where a mutated protein lacking a folded C-terminal domain (NPM1c+) has been found in the cytoplasm in patients. This aberrant localization has been linked to the development of the disease. Strategies against this subtype of acute myelogenous leukemia include the refolding of the C-terminal domain using pharmalogical chaperones and the displacement of the protein from nucleolus to nucleoplasm, which has been linked to apoptotic mechanisms.
↑Liu QR, Chan PK (March 1993). "Characterization of seven processed pseudogenes of nucleophosmin/B23 in the human genome". DNA Cell Biol. 12 (2): 149–56. doi:10.1089/dna.1993.12.149. PMID8471164.
↑ 7.07.1Sato K, Hayami R, Wu W, Nishikawa T, Nishikawa H, Okuda Y, Ogata H, Fukuda M, Ohta T (July 2004). "Nucleophosmin/B23 is a candidate substrate for the BRCA1-BARD1 ubiquitin ligase". J. Biol. Chem. 279 (30): 30919–22. doi:10.1074/jbc.C400169200. PMID15184379.
↑Li YP, Busch RK, Valdez BC, Busch H (April 1996). "C23 interacts with B23, a putative nucleolar-localization-signal-binding protein". Eur. J. Biochem. 237 (1): 153–8. doi:10.1111/j.1432-1033.1996.0153n.x. PMID8620867.
Li L, Li HS, Pauza CD, et al. (2006). "Roles of HIV-1 auxiliary proteins in viral pathogenesis and host-pathogen interactions". Cell Res. 15 (11–12): 923–34. doi:10.1038/sj.cr.7290370. PMID16354571.
Falini B, Nicoletti I, Bolli N, et al. (2007). "Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias". Haematologica. 92 (4): 519–32. doi:10.3324/haematol.11007. PMID17488663.
Venkatesh LK, Mohammed S, Chinnadurai G (1990). "Functional domains of the HIV-1 rev gene required for trans-regulation and subcellular localization". Virology. 176 (1): 39–47. doi:10.1016/0042-6822(90)90228-J. PMID2109912.
Chan PK, Chan WY, Yung BY, et al. (1986). "Amino acid sequence of a specific antigenic peptide of protein B23". J. Biol. Chem. 261 (30): 14335–41. PMID2429957.
Zhang XX, Thomis DC, Samuel CE (1989). "Isolation and characterization of a molecular cDNA clone of a human mRNA from interferon-treated cells encoding nucleolar protein B23, numatrin". Biochem. Biophys. Res. Commun. 164 (1): 176–84. doi:10.1016/0006-291X(89)91699-9. PMID2478125.
Chan WY, Liu QR, Borjigin J, et al. (1989). "Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth". Biochemistry. 28 (3): 1033–9. doi:10.1021/bi00429a017. PMID2713355.
Li XZ, McNeilage LJ, Whittingham S (1989). "The nucleotide sequence of a human cDNA encoding the highly conserved nucleolar phosphoprotein B23". Biochem. Biophys. Res. Commun. 163 (1): 72–8. doi:10.1016/0006-291X(89)92100-1. PMID2775293.
Chan PK, Aldrich M, Cook RG, Busch H (1986). "Amino acid sequence of protein B23 phosphorylation site". J. Biol. Chem. 261 (4): 1868–72. PMID3944116.
Bocker T, Bittinger A, Wieland W, et al. (1995). "In vitro and ex vivo expression of nucleolar proteins B23 and p120 in benign and malignant epithelial lesions of the prostate". Mod. Pathol. 8 (3): 226–31. PMID7542384.
Dundr M, Leno GH, Hammarskjöld ML, et al. (1995). "The roles of nucleolar structure and function in the subcellular location of the HIV-1 Rev protein". J. Cell Sci. 108 (8): 2811–23. PMID7593322.
Miyazaki Y, Takamatsu T, Nosaka T, et al. (1995). "The cytotoxicity of human immunodeficiency virus type 1 Rev: implications for its interaction with the nucleolar protein B23". Exp. Cell Res. 219 (1): 93–101. doi:10.1006/excr.1995.1209. PMID7628555.
Szebeni A, Herrera JE, Olson MO (1995). "Interaction of nucleolar protein B23 with peptides related to nuclear localization signals". Biochemistry. 34 (25): 8037–42. doi:10.1021/bi00025a009. PMID7794916.
Marasco WA, Szilvay AM, Kalland KH, et al. (1995). "Spatial association of HIV-1 tat protein and the nucleolar transport protein B23 in stably transfected Jurkat T-cells". Arch. Virol. 139 (1–2): 133–54. doi:10.1007/BF01309460. PMID7826206.
Valdez BC, Perlaky L, Henning D, et al. (1994). "Identification of the nuclear and nucleolar localization signals of the protein p120. Interaction with translocation protein B23". J. Biol. Chem. 269 (38): 23776–83. PMID8089149.